Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
, 82 (1), 82-8

Clinical Outcome of Patients Treated With Spinal Cord Stimulation for Therapeutically Refractory Angina Pectoris. The Working Group on Neurocardiology

Multicenter Study

Clinical Outcome of Patients Treated With Spinal Cord Stimulation for Therapeutically Refractory Angina Pectoris. The Working Group on Neurocardiology

I A TenVaarwerk et al. Heart.


Objective: To determine morbidity and mortality characteristics in patients treated with electrical neuromodulation for refractory angina pectoris.

Design: A retrospective multicentre study of patients treated with spinal cord stimulation between 1987 and 1997; 21 centres were contacted and 14 responded.

Setting: Specialist centres worldwide.

Patients: Questionnaires were returned on 517 patients, of whom 71% were male. One was lost to follow up. Mean (SD) age was 63.9 (10.1) years. Duration of angina pectoris was 8.1 (6.3) years.

Results: Before spinal cord stimulation, 66% of the patients had experienced myocardial infarction, 68% had three vessel disease, and in 24% the left ventricular ejection fraction (LVEF) was </= 40%. Percutaneous transluminal coronary angioplasty and bypass surgery were performed in 17% and 58% of the subjects, respectively. During a median follow up of 23 months (range 0 to 128), 103 patients died (52 from a cardiac cause, 25 from a non-cardiac cause, and 26 from an unknown cause). Annual all cause mortality was 7-8%; annual cardiovascular fatality was 3.5-5%. Mortality was univariately related to sex, number of diseased vessels, number of revascularisation procedures, previous myocardial infarction, LVEF, insulin dependent diabetes, beta blocking agents, and angiotensin converting enzyme inhibitors. Multiple variate analysis showed that LVEF, sex, beta blockers, and age >/= 71 years were independent predictors of mortality. During spinal cord stimulation, New York Heart Association functional class improved from 3.5 to 2.1 (p < 0.01); 25 of the deceased patients (24%) and 32 survivors (8%) experienced myocardial infarction; hospital admissions were significantly (p < 0.001) more common in the deceased group (66% v 37%).

Conclusions: The clinical outcome of patients with intractable angina is not adversely affected by the chronic use of neurostimulation.


Figure 1
Figure 1
Kaplan-Meier survival curve for entire group of patients. SCS, spinal cord stimulation.
Figure 2
Figure 2
Kaplan-Meier survival curve for patients with a left ventricular ejection fraction of ⩽ 40% and > 40% (see text for details). SCS, spinal cord stimulation.
Figure 3
Figure 3
Kaplan-Meier survival curves for patients with age ⩽ 71 years and > 71 years (see text for details). SCS, spinal cord stimulation.

Similar articles

See all similar articles

Cited by 15 PubMed Central articles

  • Refractory Angina: The Current State of Mechanical Therapies
    A Amritphale et al. Curr Cardiol Rep 21 (6), 46. PMID 31011835. - Review
    There is extensive ongoing research in the areas of spinal-cord stimulation, transmyocardial laser revascularization, sympathectomy, angiogenesis, and other non-cell-base …
  • Management of Refractory Angina Pectoris
    K Cheng et al. Eur Cardiol 11 (2), 69-76. PMID 30310450. - Review
    With improvements in survival from coronary artery disease (CAD) and an ageing population, refractory angina (RA) is becoming an increasingly common clinical problem faci …
  • A Prospective Study of Patients With Refractory Angina: Outcomes and the Role of High-Sensitivity Troponin T
    NT Poppi et al. Clin Cardiol 40 (1), 11-17. PMID 27754552.
    In patients with chronic refractory angina, plasma concentration of hs-cTnT is the strongest predictor of death and nonfatal MI. Notably, none of the outcomes in question …
  • Dorsal Column Stimulator Applications
    C Yampolsky et al. Surg Neurol Int 3 (Suppl 4), S275-89. PMID 23230533.
    Spinal cord stimulation is a useful tool for neuromodulation, if an accurate patient selection is carried out prior, which should include a trial period. Undoubtedly, thi …
  • Spinal Cord Stimulation in Pain Management: A Review
    YH Jeon. Korean J Pain 25 (3), 143-50. PMID 22787543.
    Spinal cord stimulation has become a widely used and efficient alternative for the management of refractory chronic pain that is unresponsive to conservative therapies. T …
See all "Cited by" articles


    1. Br Heart J. 1994 May;71(5):413-8 - PubMed
    1. Circulation. 1998 Mar 31;97(12):1157-63 - PubMed
    1. Eur Heart J. 1994 Jun;15(6):810-4 - PubMed
    1. Pacing Clin Electrophysiol. 1994 Nov;17(11 Pt 1):1751-60 - PubMed
    1. Pain. 1987 Mar;28(3):365-8 - PubMed

Publication types